OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 14 of 45

15 KEY POINTS: Diagnosing Weight-Related Metabolic and Biomechanical Complications 1. Systematic evaluation for weight-related complications should address metabolic, cardiovascular, renal, pulmonary, musculoskeletal, and other organ systems, using evidence- based screening protocols and age-appropriate diagnostic criteria. 2. Many weight-related complications remain asymptomatic until advanced stages, emphasizing the importance of proactive screening rather than symptom-driven evaluation. 3. Insulin resistance, glucose intolerance, and type 2 diabetes mellitus represent primary metabolic complications requiring early identification and aggressive management to prevent long- term complications. 4. Obesity significantly increases cardiovascular disease risk through multiple mechanisms, necessitating comprehensive risk assessment and appropriate referral for specialized evaluation when indicated. 5. Obstructive sleep apnea affects most patients with severe obesity and requires systematic screening using validated tools and appropriate referrals for sleep study evaluation. 6. Children and adolescents with obesity require age-specific screening approaches and recognition of unique complications, including orthopedic conditions and puberty disorders. 7. Preventive care is critical in patients with obesity due to increased malignancy risk and screening challenges. Assessment/Diagnosis

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026